Concordia Healthcare Corp. T.CXR.R

Reviewing the Year-end MDA...

[meetoo1600]

"On October 13, 2017, two subsidiaries of the Company, Concordia Pharmaceuticals (US), Inc. and Pinnacle Biologics, Inc. entered into an agreement with the Company’s Chief Executive Officer to guaranty payments due under the officer’s employment agreement."

 

This is how bad it has gotten.  Oberman is afraid that the Company will not have enough money even to pay his salary!

 

"Significant costs incurred during 2017 include $22,862 of costs associated with the Company's realignment of its capital structure"

What are these professionals doing?  They alone could bankrupt the company!  The figure is probably $4,000,000 or more higher by now.  The run rate is at least $3,000,000 a month.

It is difficult to find anything positive in the document.  The whole thing is a major scandal.

 

[meetoo1600]

Note that $22,862 figure in my previous post is $22,862,000. The financial figures are reported in thousands.

[daveinmiss]

Thanks again Meetoo for your excellent analysis. Maybe its their business model, maybe its management's priority to keep themselves in the money or some combination but can you see any scenario that common shares could even to to $1.00 within next 12 months?

[meetoo1600]

Yes, there are scenarios where a current share will turn out to be worth $1.00 within the next 12 months, but it would require some pretty skillful negotiation and a turn of events, neither of which I think is really in the cards. That said, there is a very real chance that the trading price could spike to over a dollar as the result of day-trader activity, such as what occurred around the middle